While concurrent mutations in their encoding genes (ARID1A and ARID1B) may co‐occur in tumours, a synthetic lethal interaction between these paralogs has been identified, wherein ARID1B deficiency selectively eliminates ARID1A‐mutant cancer cells [66]. This evidence concerns the gene ARID1B and cancer.